Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study

Wong, CY; Leung, R; Kwok, GW; Tsang, J; Li, B; Yau, T; Chiu, J

Chiu, J (通讯作者),Univ Hong Kong, Med, Hong Kong, Peoples R China.

POSTGRADUATE MEDICAL JOURNAL, 2022; 98 (1163): 666